Perrigo InvestorRoom http://perrigo.investorroom.com/ Perrigo Announces Final FDA Approval And Settlement For The Store Brand OTC Equivalent Of Nexium® 24HR Capsules http://perrigo.investorroom.com/2017-08-21-Perrigo-Announces-Final-FDA-Approval-And-Settlement-For-The-Store-Brand-OTC-Equivalent-Of-Nexium-R-24HR-Capsules Mon, 21 Aug 2017 09:00:00 -0400 http://perrigo.investorroom.com/2017-08-21-Perrigo-Announces-Final-FDA-Approval-And-Settlement-For-The-Store-Brand-OTC-Equivalent-Of-Nexium-R-24HR-Capsules Perrigo Announces FDA Final Approval for its AB Rated Generic Version of Mycolog® II Cream http://perrigo.investorroom.com/2017-08-16-Perrigo-Announces-FDA-Final-Approval-for-its-AB-Rated-Generic-Version-of-Mycolog-R-II-Cream Wed, 16 Aug 2017 08:51:00 -0400 http://perrigo.investorroom.com/2017-08-16-Perrigo-Announces-FDA-Final-Approval-for-its-AB-Rated-Generic-Version-of-Mycolog-R-II-Cream Perrigo Company plc Reports Second Quarter 2017 Financial Results http://perrigo.investorroom.com/2017-08-10-Perrigo-Company-plc-Reports-Second-Quarter-2017-Financial-Results Thu, 10 Aug 2017 02:02:00 -0400 http://perrigo.investorroom.com/2017-08-10-Perrigo-Company-plc-Reports-Second-Quarter-2017-Financial-Results Perrigo Company plc Announces Quarterly Dividend http://perrigo.investorroom.com/2017-08-08-Perrigo-Company-plc-Announces-Quarterly-Dividend Tue, 08 Aug 2017 10:51:00 -0400 http://perrigo.investorroom.com/2017-08-08-Perrigo-Company-plc-Announces-Quarterly-Dividend Perrigo Announces Tentative FDA Approval For Generic Version Of Mirvaso® Gel http://perrigo.investorroom.com/2017-08-04-Perrigo-Announces-Tentative-FDA-Approval-For-Generic-Version-Of-Mirvaso-R-Gel Fri, 04 Aug 2017 09:20:00 -0400 http://perrigo.investorroom.com/2017-08-04-Perrigo-Announces-Tentative-FDA-Approval-For-Generic-Version-Of-Mirvaso-R-Gel